Determining the Progression of In Vivo in Indications Beyond Oncology Such As Autoimmune Diseases
Time: 2:15 pm
day: Conference Day Two
Details:
- Reflecting on the application of ex vivo cell and gene therapies to consider the in vivo potential of this indication
- Analyzing pre-clinical data suggesting promise for indications outside of oncology to begin mapping out future progression towards the clinics
- Examining how the chronic but not life-threatening nature of autoimmune diseases may impact the safety concerns surrounding CAR-T treatments to evaluate their effect on in vivo
